Table 3 Baseline comparison SAH.

From: Association of sarcopenia with survival and treatment response in brain metastasis of non-small cell lung cancer

 

Controls

Metastasis

N

31

179

Female

23 (71.8%)

81 (45.3%)

Age [a, 1.Q, 3.Q]

58 (55–62.5)

63 (56–69)

CFS [1.Q, 3.Q]

3 (2–4)

3 (3–4)

CCI [1.Q, 3.Q]

2 (1–2)

9 (8–10)

TMV [cm3, 1.Q, 3.Q]

16.6 (12–21.1)

20.8 (14.2–26.7)

  1. CFS: Clinical Frailty Scale, CCI: Charlston Comorbidity Index, TMV: Temporal Muscle Volume, CM3: Cubic Centimeters.
Back to article page